Cargando…

Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study

OBJECTIVE: Knowledge about factors influencing choice of and adherence to active surveillance (AS) for prostate cancer (PC) is scarce. We aim to identify which factors most affected choosing and adhering to AS and to quantify their relative importance. DESIGN, SETTING AND PARTICIPANTS: In 2015, we s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bergengren, Oskar, Garmo, Hans, Bratt, Ola, Holmberg, Lars, Johansson, Eva, Bill-Axelson, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008427/ https://www.ncbi.nlm.nih.gov/pubmed/31874896 http://dx.doi.org/10.1136/bmjopen-2019-033944

Ejemplares similares

Changes in lifestyle among prostate cancer survivors: A nationwide population‐based study
por: Bergengren, Oskar, et al.
Publicado: (2020)

PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2019)

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022)

Satisfaction with Nurse-led Follow-up in Prostate Cancer Patients—A Nationwide Population-based Study
por: Bergengren, Oskar, et al.
Publicado: (2022)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study
por: Thomsen, Frederik B., et al.
Publicado: (2021)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
por: Ahlberg, Mats S., et al.
Publicado: (2023)

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
por: Lycken, Magdalena, et al.
Publicado: (2022)

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
por: Van Hemelrijck, Mieke, et al.
Publicado: (2010)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2015)

Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
por: Robinson, David, et al.
Publicado: (2013)

Cohort profile: The Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe)
por: Häggström, Christel, et al.
Publicado: (2017)

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2020)

High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trial
por: Nair-Shalliker, Visalini, et al.
Publicado: (2021)

Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods study
por: Fiard, Gaelle, et al.
Publicado: (2020)

Optimising the number of cores for magnetic resonance imaging‐guided targeted and systematic transperineal prostate biopsy
por: Hansen, Nienke L., et al.
Publicado: (2019)

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study
por: Plym, Anna, et al.
Publicado: (2020)

NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study
por: Dinneen, Eoin, et al.
Publicado: (2019)

A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance
por: Watts, Sam, et al.
Publicado: (2015)

Acknowledging unreported problems with active surveillance for prostate cancer: a prospective single-centre observational study
por: Hefermehl, Lukas J, et al.
Publicado: (2016)

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Implementation of Active Surveillance for Prostate Cancer: A Story of Little Pride and Much Prejudice in the Greek Health Care System
por: Kapogiannis, Filippos
Publicado: (2023)

Cohort profile: Bladder Cancer Data Base Sweden (BladderBaSe) 2.0
por: Häggström, Christel, et al.
Publicado: (2022)

TripleAiM1: a nationwide registry of de novo metastatic hormone-sensitive prostate cancer with prospective quality-of-life assessment
por: van Elst, Tessa, et al.
Publicado: (2023)

Aquablation versus holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia in medium-to-large-sized prostates (ATHLETE): protocol of a prospective randomised trial
por: Müllhaupt, Gautier, et al.
Publicado: (2021)

The Study of Active Monitoring in Sweden (SAMS): A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer
por: Bratt, Ola, et al.
Publicado: (2013)

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
por: Fallara, Giuseppe, et al.
Publicado: (2021)

Functional, oncological outcomes and safety of nephron-sparing surgery versus radical nephrectomy in patients with localised renal cell carcinoma with high anatomical complexity: a retrospective cohort study with propensity score matching method
por: Zhang, Xuanyu, et al.
Publicado: (2021)

Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
por: Merriel, Samuel W.D., et al.
Publicado: (2019)

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
por: Thomsen, Frederik B., et al.
Publicado: (2020)

Focal Cryoablation of the Prostate: Primary Treatment in 163 Patients With Localized Prostate Cancer
por: Khan, Anwar, et al.
Publicado: (2023)

Bilateral Renal Oncocytoma: Active Surveillance Versus Partial Nephrectomy
por: Sathe, Abha, et al.
Publicado: (2022)

Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
por: Rojas-Manrique, Juan P, et al.
Publicado: (2019)

Disseminated Intravascular Coagulation With Excessive Fibrinolysis Following Diagnostic Prostatic Biopsy for Prostate Cancer
por: Ghallab, Muhammad, et al.
Publicado: (2022)

Active surveillance should be considered for select men with Grade Group 2 prostate cancer
por: Pekala, Kelly R., et al.
Publicado: (2023)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

Causes of death in men with localized prostate cancer: a nationwide, population‐based study
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_54d7plc2enlhe45djun4ic3vk3